Surgery Doctors in South Hill, VA Accepting Medicare

5 Surgery doctors found. Showing 1 - 5

Dr. Yi Wei Zhang, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 416 Durant St, South Hill, VA 23970 Phone: 434-774-2581    Fax: 434-447-4075

Dr. Desiderio J Rimon, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1755 N Mecklenburg Ave, South Hill, VA 23970 Phone: 434-584-5436    Fax: 434-584-5495

Mr. Kedar Sudhakar Lavingia, Surgery - Vascular Surgery Medicare: Not Enrolled in Medicare Practice Location: 1755 N Mecklenburg Ave, South Hill, VA 23970 Phone: 434-584-5412    Fax: 434-584-5579

Jose F Demoya, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1755 N Mecklenburg Ave, South Hill, VA 23970 Phone: 434-584-5436    Fax: 434-584-5495

Michael John Tozzi, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 416 Bracey Ln, South Hill, VA 23970 Phone: 434-447-4736    Fax: 434-447-4810

News Archive

Cote d'Ivoire working to rebuild health care system under new presidential administration

"Ten months after the West African country of Cote d'Ivoire started to emerge from a presidential election crisis during which almost all hospitals and clinics had to shut down for a good six months because they had been vandalized, looted and occupied, the new government under President Alassane Ouattara is trying to make public health care a priority," including implementing "a new national health regulation, which came into effect on Mar. 1, that offers free health services to pregnant women, children under five years and people suffering from malaria," Inter Press Service reports.

Durata commences dalbavancin Phase 3 study in acute bacterial skin and skin structure infections

Durata Therapeutics today announced the Company initiated a global, pivotal, Phase 3 study (DISCOVER-1) of its lead product, dalbavancin, a long-acting, intravenous (IV) lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections (abSSSI). The pivotal study is being conducted under a Special Protocol Assessment (SPA) agreed upon with the U.S. Food and Drug Administration (FDA).

PPIs, antiplatelet drugs can help treat CV disease patients at high risk of upper GI bleeding

Using proton pump inhibitors and antiplatelet drugs (thienopyridines) together is an appropriate way of treating patients with cardiovascular disease who are at high risk of upper gastrointestinal bleeds, despite recent concerns about an adverse interaction between these two types of drugs, according to an Expert Consensus Document released jointly today by the American College of Cardiology Foundation, the American College of Gastroenterology, and the American Heart Association.

Printed human organs!

Each year, pharmaceutical companies invest millions of dollars to test drugs, many of which will never reach the market because of side effects found only during human clinical trials.

TOPEX announces sale of skin cancer business operations to SENSUS Healthcare

TOPEX, Inc. announces the sale of its skin cancer business operations to SENSUS Healthcare, LLC for its low energy SRT 100 superficial radiotherapy treatment system. Since TOPEX received FDA approval during 2007, many systems have been operating worldwide at hospital radiation oncology centers, dermatology and veterinary oncology practices for the treatment of skin cancer.

Read more Medical News

› Verified 8 days ago